Pharmacology, Toxicology and Pharmaceutical Science
Inflammatory Arthritis
87%
Rheumatoid Arthritis
87%
Disease Activity
35%
Remission
30%
Methotrexate
17%
Randomized Controlled Trial
9%
Adalimumab
9%
Disease Activity Score
9%
Inflammation
7%
Cyclic Citrullinated Peptide Antibody
7%
Placebo
7%
Diseases
6%
Glucocorticoid
6%
Synovitis
5%
Disease Modifying Antirheumatic Drug
5%
Abatacept
5%
Medicine and Dentistry
Inflammatory Arthritis
73%
Rheumatoid Arthritis
73%
Magnetic Resonance Imaging
25%
Disease Activity
17%
Methotrexate
15%
DAS28
10%
Spontaneous Remission
9%
Randomized Controlled Trial
8%
Glucocorticoid
7%
Clinical Disease Activity Index
6%
Tocilizumab
6%
Arm
6%
Abatacept
5%
Synovitis
5%
Cyclosporine
5%
Disease Modifying Antirheumatic Drug
5%
Placebo
5%
Immunology and Microbiology
Inflammatory Arthritis
100%
Magnetic Resonance Imaging
18%
Blood Plasma
14%
Methotrexate
13%
Blood Level
12%
Synovitis
10%
Adalimumab
9%
Anti-Citrullinated Protein Antibody
8%
Disease-Modifying Antirheumatic Drug
8%
Rheumatoid Factor
6%
Peptides
6%
Autoantibodies
6%
Arthritis
5%
Normal Human
5%
Galectin 3
5%
